Related Experiment Videos
Increased pupillary sensitivity to pilocarpine in depression
1Psychiatry Service, Veterans Administration Medical Center, Long Beach, CA, USA.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|February 1, 1996
Summary
This study found increased muscarinic receptor sensitivity in major depression. Depressed patients showed greater pupillary constriction to pilocarpine, suggesting a potential biomarker for depression.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Muscarinic receptor sensitivity alterations are implicated in major depressive disorder.
- Understanding these changes may offer insights into depression pathophysiology.
Purpose of the Study:
- To investigate the hypothesis of heightened muscarinic receptor sensitivity in patients with major depression.
- To explore pupillary response to pilocarpine as a potential indicator of depression.
Main Methods:
- Compared pupillary responses to pilocarpine (0.08%-0.23%) in 10 male patients with major depression and matched controls.
- Controlled for individual differences in pupil size by assessing responses under maximal dilation after cholinergic blockade with tropicamide (0.5%).
Main Results:
- Depressed patients exhibited significantly greater pupillary diameter reductions compared to controls when administered pilocarpine (0.095%-0.185%).
- This difference remained significant even after adjusting for baseline dilated pupil size.
Conclusions:
- The findings support the hypothesis of increased muscarinic receptor sensitivity in major depression.
- Pupillary sensitivity to pilocarpine may serve as a discriminating factor between depressed individuals and healthy controls.